Genmab A/S (NASDAQ:GMAB) Q2 2025 Earnings Call Transcript August 7, 2025
Genmab A/S beats earnings expectations. Reported EPS is $0.54, expectations were $0.39.
Operator: Hello, and welcome to the Genmab First Half 2025 Financial Results Conference Call. As a reminder, this conference call is being recorded. During this telephone conference, you may be presented with forward-looking statements that include words such as believes, anticipates, plans or expects. Actual results may differ...
